Natraj Proteins Ltd Upgraded to Sell on Technical Improvements and Financial Recovery

Quality Assessment: Persistent Fundamental Weakness Despite Recent Profit Growth

While Natraj Proteins has demonstrated a positive financial performance in the third quarter of FY25-26, the company’s long-term fundamental strength remains weak. Over the past five years, the firm has recorded a negative compound annual growth rate (CAGR) of -5.06% in net sales, indicating a contraction in its core revenue base. This trend highlights structural challenges within the edible oil sector or company-specific operational issues.

Profitability metrics further underscore these concerns. The average Return on Equity (ROE) stands at a modest 6.97%, signalling limited efficiency in generating profits from shareholders’ funds. Despite this, the latest six-month period has seen a remarkable 226.53% growth in Profit After Tax (PAT), reaching ₹1.24 crore, and the quarterly Profit Before Depreciation, Interest and Taxes (PBDIT) peaked at ₹3.54 crore. Operating profit margin to net sales also improved to 12.30%, marking the highest level recorded recently.

However, these positive developments have not yet translated into a robust turnaround in the company’s overall quality grade, which remains subdued due to the persistent underperformance against benchmarks and weak long-term growth.

Valuation: Attractive Metrics Amid Discounted Pricing

Natraj Proteins currently trades at ₹33.39, down from the previous close of ₹36.90, and well below its 52-week high of ₹47.90. The stock’s valuation appears attractive relative to its peers, with an Enterprise Value to Capital Employed (EV/CE) ratio of 0.7, suggesting it is trading at a discount. This valuation is supported by a Return on Capital Employed (ROCE) of 1%, which, while low, indicates some efficiency in capital utilisation.

Moreover, the company’s Price/Earnings to Growth (PEG) ratio stands at a notably low 0.1, reflecting the market’s cautious stance despite the recent profit surge. This low PEG ratio may appeal to value investors seeking turnaround opportunities in micro-cap stocks within the edible oil sector.

Financial Trend: Mixed Signals with Recent Profitability Gains

Examining the financial trend, Natraj Proteins has delivered mixed returns over various time horizons. The stock outperformed the Sensex over short-term periods, with a 7.40% return in the past week and 13.65% in the last month, compared to the Sensex’s negative returns of -1.03% and -10.33% respectively. Year-to-date, the stock posted a modest 4.34% gain while the Sensex declined by 15.57%.

However, over longer periods, the company has underperformed significantly. The one-year return was -14.27%, trailing the Sensex’s -7.06%, and the three-year return was -15.66% against the Sensex’s robust 24.13%. Even over five and ten years, the stock’s returns of 19.04% and 27.93% lag behind the Sensex’s 43.50% and 183.94% respectively. This consistent underperformance highlights the challenges in sustaining growth and shareholder value creation.

Technical Analysis: Upgrade Driven by Improved Short-Term Indicators

The primary catalyst for the upgrade from Strong Sell to Sell is the shift in technical grading. The technical trend has improved from bearish to mildly bearish, reflecting a subtle but meaningful change in market sentiment. Key technical indicators present a mixed but cautiously optimistic picture:

• MACD: Weekly readings are mildly bullish, signalling potential upward momentum in the short term, although monthly readings remain bearish.
• RSI: Both weekly and monthly Relative Strength Index (RSI) show no clear signal, indicating a neutral momentum without overbought or oversold conditions.
• Bollinger Bands: Weekly bands suggest sideways movement, while monthly bands remain mildly bearish, pointing to limited volatility and a lack of strong directional bias.
• Moving Averages: Daily moving averages are mildly bearish, consistent with the recent price decline from ₹36.90 to ₹33.39.
• KST (Know Sure Thing): Weekly KST is mildly bullish, supporting the short-term positive momentum, but monthly KST remains bearish.
• Dow Theory: Weekly data shows no clear trend, while monthly data is mildly bearish, reflecting uncertainty in the broader market context.

Overall, these technical signals suggest that while the stock is not yet in a strong uptrend, the worst of the bearish momentum may be abating, justifying the upgrade in technical grade and the overall rating.

Market Capitalisation and Shareholding

Natraj Proteins is classified as a micro-cap stock, which inherently carries higher volatility and risk. The majority of its shares are held by non-institutional investors, which may contribute to less stable trading patterns and liquidity concerns. This shareholder composition often results in price swings driven by retail sentiment rather than institutional confidence.

Conclusion: Cautious Optimism Amid Lingering Risks

The upgrade of Natraj Proteins Ltd’s investment rating to Sell from Strong Sell reflects a cautious shift in outlook driven primarily by improved technical indicators and recent positive quarterly results. Despite these encouraging signs, the company’s weak long-term fundamentals, including negative sales growth and low profitability, continue to weigh heavily on its investment appeal.

Valuation metrics suggest the stock is attractively priced relative to peers, offering potential upside if the company can sustain its recent profit growth. However, investors should remain mindful of the stock’s micro-cap status, volatile price movements, and consistent underperformance against broader market indices over multiple years.

In summary, Natraj Proteins presents a complex investment case where short-term momentum and valuation discounts offer some appeal, but fundamental weaknesses and mixed technical signals counsel prudence. The current Sell rating reflects this balanced view, recommending investors monitor developments closely before considering exposure.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →